EP Patent

EP3495023A1 — Semifluorinated compounds and their compositions

Assigned to Novaliq GmbH · Expires 2019-06-12 · 7y expired

What this patent protects

The present invention is directed to compositions comprising semifluorinated compounds and their use as medicaments for topical administration to the eye.

USPTO Abstract

The present invention is directed to compositions comprising semifluorinated compounds and their use as medicaments for topical administration to the eye.

Drugs covered by this patent

Patent Metadata

Patent number
EP3495023A1
Jurisdiction
EP
Classification
—
Expires
2019-06-12
Drug substance claim
No
Drug product claim
No
Assignee
Novaliq GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.